Sinopep-Allsino Biopharmaceutical Co. Ltd. A Financial Flexibility Index
Sinopep-Allsino Biopharmaceutical Co. Ltd. A financial flexibility index. Sinopep-Allsino Biopharmaceutical Co. Ltd. A (688076) has a Financial Flexibility Index of 0.11x as of September 2025. Free cash flow of CN¥405.72 Million (operating CF CN¥68.66 Million minus capex CN¥337.06 Million) represents 0% of total liabilities (CN¥3.56 Billion). See Sinopep-Allsino Biopharmaceutical Co. Lt (688076) free cash flow to measure how efficiently the company converts operating cash flow to free cash.
Financial Flexibility Index
Free Cash Flow
Total Liabilities
Capital Expenditures
Financial Flexibility Index of Sinopep-Allsino Biopharmaceutical Co. Ltd. A (2013–2025)
Financial flexibility index of Sinopep-Allsino Biopharmaceutical Co. Ltd. A from 2013 to 2025. Historical Financial Flexibility Index trend for Sinopep-Allsino Biopharmaceutical Co. Ltd. A across 13 annual periods. Check Sinopep-Allsino Biopharmaceutical Co. Lt earnings quality ratio to evaluate the quality of earnings relative to operating cash generation.
Sinopep-Allsino Biopharmaceutical Co. Ltd. A Financial Flexibility Index by Year (2013–2025)
Sinopep-Allsino Biopharmaceutical Co. Ltd. A financial flexibility index by year from 2013 to 2025. Year-by-year free cash flow to debt coverage for Sinopep-Allsino Biopharmaceutical Co. Ltd. A. For the full cash flow conversion analysis, see Sinopep-Allsino Biopharmaceutical Co. Lt cash conversion from operations.
| Year | Flexibility Index | Free Cash Flow (CNY) | Operating CF | Total Liabilities | YoY Change |
|---|---|---|---|---|---|
| 2025 | 0.55x | CN¥2.05 Billion | CN¥681.24 Million | CN¥3.74 Billion | ▼ -11.9% |
| 2024 | 0.62x | CN¥1.49 Billion | CN¥400.12 Million | CN¥2.40 Billion | ▼ -16.4% |
| 2023 | 0.74x | CN¥1.01 Billion | CN¥350.21 Million | CN¥1.36 Billion | ▼ -4.9% |
| 2022 | 0.78x | CN¥467.65 Million | CN¥29.29 Million | CN¥597.41 Million | ▼ -39.9% |
| 2021 | 1.30x | CN¥414.10 Million | CN¥180.75 Million | CN¥318.14 Million | ▲ +121.3% |
| 2020 | 0.59x | CN¥252.66 Million | CN¥141.38 Million | CN¥429.55 Million | ▼ -26.0% |
| 2019 | 0.80x | CN¥322.52 Million | CN¥46.14 Million | CN¥405.54 Million | ▼ -28.1% |
| 2018 | 1.11x | CN¥293.54 Million | CN¥96.06 Million | CN¥265.47 Million | ▲ +280.1% |
| 2017 | 0.29x | CN¥84.45 Million | CN¥11.11 Million | CN¥290.27 Million | ▲ +436.8% |
| 2016 | -0.09x | CN¥-10.81 Million | CN¥-21.95 Million | CN¥125.16 Million | ▲ +89.4% |
| 2015 | -0.82x | CN¥-100.55 Million | CN¥-112.62 Million | CN¥123.35 Million | ▼ -281.2% |
| 2014 | 0.45x | CN¥77.87 Million | CN¥68.18 Million | CN¥173.05 Million | ▲ +7.5% |
| 2013 | 0.42x | CN¥68.30 Million | CN¥43.67 Million | CN¥163.12 Million | — |